Ablacon Inc, based in Wheat Ridge, CO, is a cutting-edge medical technology company specializing in the visualization and treatment of atrial fibrillation. Their innovative electrographic flow technology provides real-time insights into the heart, enabling faster, more precise, and reliable treatment of this common cardiac condition.
With FDA 510 k clearance, Ablacon's Ablamap System and Ablacath are designed for use by physicians, offering a comprehensive solution to address atrial fibrillation. By leveraging their advanced products, healthcare professionals can effectively diagnose and treat patients, improving outcomes and enhancing the quality of care.
Generated from the website